Acute Lymphoblastic Leukemia in Remission
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia in Remission.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Weight Gain in Pediatric Leukemia Survivors [NA]
A clinical trial examining weight gain in pediatric leukemia survivors, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion [NA]
Clinical trial update from Baylor College of Medicine reports results for haploidentical hematopoietic cell transplantation using TCR alpha/…
-
CLINICAL_TRIALS other · 2025-04-29Clinical Trial Update: MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing [NA]
Clinical trial update from the Medical College of Wisconsin describes a study using targeted antithymocyte globulin dosing to deplete alpha/…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [Phase 2]
Phase 2 clinical trial evaluating treosulfan, fludarabine phosphate, and total-body irradiation as conditioning for umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2023-02-10Clinical Trial Update: CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment [Phase 1, Phase 2]
A early-phase clinical trial investigating CD19 CAR-T cells and CD19-positive feeder T cells as consolidation therapy for acute lymphoblasti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [Phase 1]
Phase 1 trial of a conditioning regimen including an iodine-131 labeled monoclonal antibody with fludarabine, cyclophosphamide, total-body i…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes [Phase 2]
Phase 2 trial evaluating donor umbilical cord blood transplant with or without ex-vivo expanded cord blood progenitor cells in patients with…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tandem CAR T cells targeting CD19 and CD22 for relapsed or chemotherapy-refractory B-cell malignancies.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate
This clinical trial update summarizes how young patients with acute lymphoblastic leukemia responded to or developed resistance to methotrex…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial updating the use of deferasirox for iron overload due to transfusions in patients with hematologic malignancies; study status …